-

Sunnybrook Health Sciences Centre selects Allscripts iProcedures

Canada provider to implement Allscripts iProcedures Anesthesia system to drive effective electronic documentation and charting

TORONTO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Canada’s Sunnybrook Health Sciences Centre is continuing its partnership with Allscripts by implementing the iProcedures electronic Anesthesia Information Management Solution (AIMS). The solution will be used in all operating rooms, labour and delivery and other anesthesia-related areas at Sunnybrook Health Sciences Centre’s Bayview and Holland Centre sites.

Sunnybrook Health Sciences Centre began as a hospital for Canadian veterans, and has since grown into a fully affiliated teaching hospital of the University of Toronto, evolving to meet the needs of its growing community. The hospital sees nearly 1.3 million patients each year across three campuses and is also home to Canada's largest trauma centre. Sunnybrook's groundbreaking research changes the way patients are treated around the world.

Already an Allscripts Patient Flow™ user, Sunnybrook Health Sciences Centre looks to uphold its vision to invent the future of healthcare by implementing iProcedures AIMS to enable users to create complete anesthesia records through automated collection and storage of data from anesthesia-related machines. The iProcedures solution can reduce duplication of documentation, improve efficiency of perioperative process, provide data analysis to aid decision making and generate reports for quality assurance and for research proposes.

“In Allscripts, we have a dedicated partner, one that shares our mission of driving the best care for our patients when it matters most,” said Dr. Andy Smith, Sunnybrook’s president and CEO. “Ensuring our surgical departments have the most comprehensive tools is critical to our continued success.”

iPro Anesthesia is a cloud-based, mobile anesthesia information management system designed by anesthesiologists to automate anesthesia documentation and offer true clinician-driven functionality. A comprehensive end-to-end solution that can produce a more complete, compliant and legible anesthesia record, it can improve documentation, operating room efficiency, patient safety and medication management.

“We’re proud to expand our successful partnership with Sunnybrook,” said Allscripts CEO Paul Black. “Documentation is an important element across all clinical departments and it’s an especially critical measure in the operating theatre. With iProcedures AIMS, Sunnybrook has chosen the solution it needs to deliver the excellent care Sunnybrook’s patients expect.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom